Summit Trail Advisors’s Axcelis ACLS Stock Holding History

Summit Trail Advisors’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-32	Closed	-$1K	–	427
2017 Q4	$1K	Buy	+32	New	+$1.01K	﹤0.01%	1738

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Summit Trail Advisors's ACLS Position: Q1 2018 in Review

Summit Trail Advisors sold out of Axcelis (ACLS) in Q1 2018, closing a stake of 32 shares — an estimated $1K sold.

Summit Trail Advisors first reported a position in ACLS in Q4 2017 and held it in 1 quarter. The position peaked at $1K in Q4 2017. 165 funds tracked by Wall St. Rank hold ACLS as of Q1 2018.

Summit Trail Advisors reported no remaining Axcelis position as of Q1 2018 after selling out during the quarter.
Summit Trail Advisors sold 32 Axcelis shares in Q1 2018, an estimated $1K.
Summit Trail Advisors first reported a position in Axcelis in Q4 2017 and held it in 1 quarter.
Summit Trail Advisors's Axcelis position peaked at $1K in Q4 2017.
165 funds tracked by Wall St. Rank held Axcelis as of Q1 2018.

Based on Summit Trail Advisors's 13F filing for Q1 2018, filed 21 May 2018.